•Furthermore, observed changes in human proteins such as AMY2A suggested an increased glucose uptake in advanced kidney disease (for example, when comparing CKD4 to CKD1), resulting in potential glucose imbalance and reduced digestion of starch; this further suggests reduced saccharolytic fermentation, crucial for the synthesis of SCFAs. The gene discussed is AMY2A; the disease is kidney disorder.